Rigel Pharmaceuticals (RIGL) Depreciation & Amortization (CF) (2010 - 2026)
Rigel Pharmaceuticals' quarterly Depreciation & Amortization (CF) came in at $597000.0 in Q1 2026, down 1.16% year-on-year from $604000.0 in Q1 2025, and down 0.67% quarter-over-quarter from $601000.0 in Q4 2025.
Rigel Pharmaceuticals has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $597000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 1.16% year-over-year to $597000.0; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (down 0.99% YoY), and the FY2025 full-year result was $2.4 million, up 8.39% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $597000.0, down from $601000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $613000.0 in Q2 2024, with the low at $237000.0 in Q1 2022.
- Average Depreciation & Amortization (CF) over 5 years is $439764.7, with a median of $400000.0 recorded in 2024.
- Year-over-year, Depreciation & Amortization (CF) dropped 29.7% in 2022 and jumped 109.25% in 2024.
- Tracing RIGL's Depreciation & Amortization (CF) over 5 years: stood at $284000.0 in 2022, then gained by 3.17% to $293000.0 in 2023, then jumped by 106.14% to $604000.0 in 2024, then declined by 0.5% to $601000.0 in 2025, then slipped by 0.67% to $597000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $597000.0 (Q1 2026), $601000.0 (Q4 2025), and $603000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 597,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 597,000.00 |
| Mar 31, 2026 | 597,000.00 |
| Dec 31, 2025 | 601,000.00 |
| Dec 31, 2025 | 601,000.00 |
| Sep 30, 2025 | 603,000.00 |
| Sep 30, 2025 | 603,000.00 |
| Jun 30, 2025 | 607,000.00 |
| Jun 30, 2025 | 607,000.00 |
| Mar 31, 2025 | 604,000.00 |
| Mar 31, 2025 | 604,000.00 |
| Dec 31, 2024 | 604,000.00 |
| Dec 31, 2024 | 604,000.00 |
| Sep 30, 2024 | 611,000.00 |
| Sep 30, 2024 | 611,000.00 |
| Jun 30, 2024 | 613,000.00 |
| Jun 30, 2024 | 613,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | 293,000.00 |
| Dec 31, 2023 | 293,000.00 |
| Sep 30, 2023 | 292,000.00 |
| Sep 30, 2023 | 292,000.00 |
| Jun 30, 2023 | 296,000.00 |
| Jun 30, 2023 | 296,000.00 |
| Mar 31, 2023 | 357,000.00 |
| Mar 31, 2023 | 357,000.00 |
| Dec 31, 2022 | 284,000.00 |
| Dec 31, 2022 | 284,000.00 |
| Sep 30, 2022 | 240,000.00 |
| Sep 30, 2022 | 240,000.00 |
| Jun 30, 2022 | 237,000.00 |
| Jun 30, 2022 | 237,000.00 |
| Mar 31, 2022 | 237,000.00 |
| Mar 31, 2022 | 237,000.00 |
| Dec 31, 2021 | 404,000.00 |
| Dec 31, 2021 | 404,000.00 |
| Sep 30, 2021 | 261,000.00 |
| Sep 30, 2021 | 261,000.00 |
| Jun 30, 2021 | 258,000.00 |
| Jun 30, 2021 | 258,000.00 |
| Mar 31, 2021 | 239,000.00 |
| Mar 31, 2021 | 239,000.00 |
| Dec 31, 2020 | 206,000.00 |
| Dec 31, 2020 | 206,000.00 |
| Sep 30, 2020 | 165,000.00 |
| Sep 30, 2020 | 165,000.00 |
| Jun 30, 2020 | 164,000.00 |
| Jun 30, 2020 | 164,000.00 |
| Mar 31, 2020 | 171,000.00 |
| Mar 31, 2020 | 171,000.00 |
| Dec 31, 2019 | 180,000.00 |
| Dec 31, 2019 | 180,000.00 |
| Sep 30, 2019 | 166,000.00 |
| Sep 30, 2019 | 166,000.00 |
| Jun 30, 2019 | 173,000.00 |
| Jun 30, 2019 | 173,000.00 |
| Mar 31, 2019 | 164,000.00 |
| Mar 31, 2019 | 164,000.00 |
| Dec 31, 2018 | 163,000.00 |
| Dec 31, 2018 | 163,000.00 |
| Sep 30, 2018 | 159,000.00 |
| Sep 30, 2018 | 159,000.00 |
| Jun 30, 2018 | 159,000.00 |
| Jun 30, 2018 | 159,000.00 |
| Mar 31, 2018 | 113,000.00 |
| Mar 31, 2018 | 113,000.00 |
| Dec 31, 2017 | 113,000.00 |
| Dec 31, 2017 | 113,000.00 |
| Sep 30, 2017 | 112,000.00 |
| Sep 30, 2017 | 112,000.00 |
| Jun 30, 2017 | 114,000.00 |
| Jun 30, 2017 | 114,000.00 |
| Mar 31, 2017 | 126,000.00 |
| Mar 31, 2017 | 126,000.00 |
| Dec 31, 2016 | 143,000.00 |
| Dec 31, 2016 | 143,000.00 |
| Sep 30, 2016 | 214,000.00 |
| Sep 30, 2016 | 214,000.00 |
| Jun 30, 2016 | 260,000.00 |
| Jun 30, 2016 | 260,000.00 |
| Mar 31, 2016 | 324,000.00 |
| Mar 31, 2016 | 324,000.00 |
| Dec 31, 2015 | 338,000.00 |
| Dec 31, 2015 | 338,000.00 |
| Sep 30, 2015 | 287,000.00 |
| Sep 30, 2015 | 287,000.00 |
| Jun 30, 2015 | 379,000.00 |
| Jun 30, 2015 | 379,000.00 |
| Mar 31, 2015 | 435,000.00 |
| Mar 31, 2015 | 435,000.00 |
| Dec 31, 2014 | 507,000.00 |
| Dec 31, 2014 | 507,000.00 |
| Sep 30, 2014 | 574,000.00 |
| Sep 30, 2014 | 574,000.00 |
| Jun 30, 2014 | 623,000.00 |
| Jun 30, 2014 | 623,000.00 |
| Mar 31, 2014 | 655,000.00 |
| Mar 31, 2014 | 655,000.00 |
| Dec 31, 2013 | 651,000.00 |
| Dec 31, 2013 | 651,000.00 |
| Sep 30, 2013 | 644,000.00 |
| Sep 30, 2013 | 644,000.00 |
| Jun 30, 2013 | 628,000.00 |
| Jun 30, 2013 | 628,000.00 |
| Mar 31, 2013 | 669,000.00 |
| Mar 31, 2013 | 669,000.00 |
| Dec 31, 2012 | 636,000.00 |
| Dec 31, 2012 | 636,000.00 |
| Sep 30, 2012 | 635,000.00 |
| Sep 30, 2012 | 635,000.00 |
| Jun 30, 2012 | 610,000.00 |
| Jun 30, 2012 | 610,000.00 |
| Mar 31, 2012 | 552,000.00 |
| Mar 31, 2012 | 552,000.00 |
| Dec 31, 2011 | 526,000.00 |
| Dec 31, 2011 | 526,000.00 |
| Sep 30, 2011 | 506,000.00 |
| Sep 30, 2011 | 506,000.00 |
| Jun 30, 2011 | 476,000.00 |
| Jun 30, 2011 | 476,000.00 |
| Mar 31, 2011 | 447,000.00 |
| Mar 31, 2011 | 447,000.00 |
| Dec 31, 2010 | 393,000.00 |
| Dec 31, 2010 | 393,000.00 |
| Sep 30, 2010 | 327,000.00 |
| Sep 30, 2010 | 327,000.00 |